Cornelia Feiterna-Sperling

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants
    Cornelia Feiterna-Sperling
    Charite, Department of Pediatric Pneumology and Immunology, University Medicine Berlin, Berlin, Germany
    J Acquir Immune Defic Syndr 45:43-51. 2007
  2. ncbi Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant
    Cornelia Feiterna-Sperling
    Department of Pediatric Pneumology, Charite, University Medicine Berlin, Berlin, Germany
    Pediatr Infect Dis J 27:564-7. 2008
  3. ncbi A 12-year-old boy with multidrug-resistant human immunodeficiency virus type 1 successfully treated with HAART including ritonavir-boosted tipranavir oral solution and enfuvirtide
    Cornelia Feiterna-Sperling
    Charite, Campus Virchow Klinikum, Department of Pediatric Pneumology and Immunology, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur J Med Res 14:44-6. 2009
  4. ncbi Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children
    Cornelia Feiterna-Sperling
    Department of Pediatric Pneumology and Immunology, Helmut Ruska Haus, Charite Universitatsmedizin Berlin, Berlin, Germany
    Clin Infect Dis 51:e90-4. 2010
  5. ncbi Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence
    Henrik Mueller
    Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany
    PLoS ONE 6:e29367. 2011
  6. ncbi Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents
    Juan C Salazar
    Connecticut Children s Medical Center, University of Connecticut School of Medicine, Hartford, Connecticut 06106, USA
    AIDS 22:1789-98. 2008
  7. ncbi Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates
    Thomas Schmitz
    AIDS 20:1082-3. 2006

Detail Information

Publications7

  1. ncbi Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants
    Cornelia Feiterna-Sperling
    Charite, Department of Pediatric Pneumology and Immunology, University Medicine Berlin, Berlin, Germany
    J Acquir Immune Defic Syndr 45:43-51. 2007
    ..A prospective observational study to investigate hematologic alterations during the first 3 months of life in HIV-exposed uninfected infants subjected to antiretroviral medication before and after birth...
  2. ncbi Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant
    Cornelia Feiterna-Sperling
    Department of Pediatric Pneumology, Charite, University Medicine Berlin, Berlin, Germany
    Pediatr Infect Dis J 27:564-7. 2008
    ..Here, we report the case of a preterm infant with HIV-related life-threatening PAH, which resolved after initiation of highly active antiretroviral therapy...
  3. ncbi A 12-year-old boy with multidrug-resistant human immunodeficiency virus type 1 successfully treated with HAART including ritonavir-boosted tipranavir oral solution and enfuvirtide
    Cornelia Feiterna-Sperling
    Charite, Campus Virchow Klinikum, Department of Pediatric Pneumology and Immunology, Augustenburger Platz 1, 13353 Berlin, Germany
    Eur J Med Res 14:44-6. 2009
    ....
  4. ncbi Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children
    Cornelia Feiterna-Sperling
    Department of Pediatric Pneumology and Immunology, Helmut Ruska Haus, Charite Universitatsmedizin Berlin, Berlin, Germany
    Clin Infect Dis 51:e90-4. 2010
    ..Oseltamivir shortened the duration of viral shedding...
  5. ncbi Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence
    Henrik Mueller
    Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany
    PLoS ONE 6:e29367. 2011
    ..Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We investigated granulysin as a candidate immune marker for childhood and adolescent TB...
  6. ncbi Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents
    Juan C Salazar
    Connecticut Children s Medical Center, University of Connecticut School of Medicine, Hartford, Connecticut 06106, USA
    AIDS 22:1789-98. 2008
    ..To evaluate the efficacy, safety and tolerability of ritonavir-boosted tipranavir (TPV/r) in HIV-1-infected pediatric patients...
  7. ncbi Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates
    Thomas Schmitz
    AIDS 20:1082-3. 2006